Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: A contemporary series

Abstract

Femoropopliteal PTA can be performed with a low perioperative morbidity and mortality. Intermediate primary patency is directly related to TASC classification. Although secondary intervention is often necessary to maintain patency in TASC C/D lesions, these data suggest that it would be appropriate to use PTA as initial therapy for chronic femoropopliteal occlusive disease regardless of clinical classification at presentation or TASC category of lesion severity.

Comparison of Clinical Outcome of Infrapopliteal Angioplasty Between Korean Diabetic and Non-Diabetic Patients With Critical Limb Ischemia

“…5,8,12-14 Infrapopliteal angioplasty, however, has been criticized because of the small diameter and length of the treated vessel, both of which have a tendency towards a high restenosis rate; furthermore, it is not clear whether the clinical success of infrapopliteal angioplasty is due solely to technical success. [23][24][25][26] A previous study evaluated the effectiveness of PTA as the first-choice revascularization procedure in diabetic patients with CLI. 5 It was reported that 1.7% of patients experienced major amputations; that 5-year primary patency was 88%; and that 5-year survival was 74%.…”

Comparison of Clinical outcomes of Infragenicular Angioplasty between diabetic and non-diabetic patients with Peripheral Arterial Occlusive Disease

“…As a result of small size and length of the treated arteries, infragenicular angioplasty had been accused by a high restenosis rate; moreover, it is still vague whether the clinical success of infragenicular angioplasty is a result of technical success alone [24][25][26][27]. The technical success rate in our study was 98.4% in diabetic group and 100% in non-diabetic group.…”

Endovascular Treatment of Diabetic Foot in a Selected Population of Patients with Below-the-Knee Disease: Is the Angiosome Model Effective?

“…Several other studies [23][24][25][26][27][28][29][30] evaluated the effectiveness of PTA in diabetic foot patients, but these studies are limited by their main conditions, including a heterogeneous population with BTK and/or ATK disease. Moreover, the effectiveness of BTK-area PTA is still a matter of debate; the small size of the treated vessels appears to be associated with an increased rate of restenosis, and in patients with chronic ATK and BTK knee disease, it is unclear whether the clinical success is linked to the PTA of either the ATK or BTK area alone [33].…”